S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
S&P 500   3,778.99 (-0.11%)
DOW   30,192.43 (-0.27%)
QQQ   281.20 (-0.28%)
AAPL   146.13 (-0.18%)
MSFT   248.36 (-0.34%)
META   138.55 (-0.31%)
GOOGL   100.99 (-0.43%)
AMZN   120.70 (-0.21%)
TSLA   239.38 (-0.59%)
NVDA   131.86 (-0.17%)
NIO   15.96 (-0.50%)
BABA   84.14 (-0.30%)
AMD   67.81 (-0.19%)
T   15.63 (-1.88%)
MU   54.51 (-0.40%)
CGC   3.12 (+1.63%)
F   12.42 (-0.72%)
DIS   100.79 (+-0.01%)
AMC   7.37 (+0.55%)
PYPL   93.54 (-0.31%)
PFE   43.94 (-0.41%)
NFLX   235.94 (-0.33%)
NYSE:CNC

Centene - CNC Price Target & Analyst Ratings

$80.81
-0.06 (-0.07%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$79.69
$81.34
50-Day Range
$77.30
$97.22
52-Week Range
$60.81
$98.53
Volume
2.93 million shs
Average Volume
4.70 million shs
Market Capitalization
$46.19 billion
P/E Ratio
25.65
Dividend Yield
N/A
Price Target
$97.85

Centene Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 18 Analyst Ratings

Consensus Analyst Price Target

$97.85
21.09% Upside
High Prediction$115.00
Average Prediction$97.85
Low Prediction$77.00
TypeCurrent
10/6/21 to 10/6/22
1 Month Ago
9/6/21 to 9/6/22
3 Months Ago
7/8/21 to 7/8/22
1 Year Ago
10/6/20 to 10/6/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
15 Buy rating(s)
13 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$97.85$98.26$92.59$81.79
Predicted Upside21.09% Upside17.21% Upside17.62% Upside21.81% Upside
Get Centene Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.


CNC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Centene Stock vs. The Competition

TypeCenteneMedical CompaniesS&P 500
Consensus Rating Score
2.72
2.68
2.49
Consensus RatingModerate BuyBuyHold
Predicted Upside21.09% Upside1,080.30% Upside27.51% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
979
74.39%
Underperform Votes
337
25.61%
Avg. Outperform Votes
166
66.67%
Avg. Underperform Votes
83
33.33%
Avg. Outperform Votes
853
68.40%
Avg. Underperform Votes
394
31.60%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/3/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$107.00 ➝ $100.00+28.52%
9/30/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$90.00+15.86%
9/22/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$108.00 ➝ $101.00+27.14%
8/26/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$103.00 ➝ $99.00+3.42%
7/27/2022Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$110.00+18.64%
7/27/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$110.00+18.64%
7/27/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$102.00 ➝ $110.00+19.36%
7/27/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$91.00 ➝ $99.00+6.28%
7/19/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A.J. Rice
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$97.00+6.19%
7/14/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$82.00 ➝ $115.00+34.99%
6/23/2022Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$112.00 ➝ $103.00+22.66%
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+30.38%
5/26/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$111.00 ➝ $108.00+31.88%
5/26/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$95.00 ➝ $90.00+5.50%
2/9/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$78.00 ➝ $84.00-1.95%
12/14/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$83.00+6.21%
12/13/2021Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$72.00 ➝ $80.00+2.38%
12/13/2021BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $100.00+27.47%
11/1/2021Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$77.00+8.09%
8/17/2021Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy
7/9/2021Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
12/14/2020SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
D. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform$80.00 ➝ $75.00+23.54%
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$83.00 ➝ $89.00+25.14%
4/13/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$85.00 ➝ $90.00+35.50%
2/5/2020JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral ➝ Overweight$88.00+42.00%
2/3/2020Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$90.00+43.29%
12/16/2019Piper Jaffray Companies
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sarah James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$80.00+33.29%
(Data available from 10/6/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












CNC Price Target - Frequently Asked Questions

What is Centene's consensus rating and price target?

According to the issued ratings of 18 analysts in the last year, the consensus rating for Centene stock is Moderate Buy based on the current 5 hold ratings and 13 buy ratings for CNC. The average twelve-month price prediction for Centene is $97.85 with a high price target of $115.00 and a low price target of $77.00. Learn more on CNC's analyst rating history.

Do Wall Street analysts like Centene more than its competitors?

Analysts like Centene more than other Medical companies. The consensus rating for Centene is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how CNC compares to other companies.

Do MarketBeat users like Centene more than its competitors?

MarketBeat users like Centene more than other Medical companies. 74.39% of MarketBeat users gave Centene an outperform vote while medical companies recieve an average of 66.67% outperform votes by MarketBeat users.

Is Centene being upgraded or downgraded by Wall Street analysts?

Over the previous 90 days, Centene's stock had 1 upgrade and 1 downgrade by analysts.

Does Centene's stock price have much upside?

According to analysts, Centene's stock has a predicted upside of 17.33% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:CNC) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.